Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?

Palmer, S., Sculpher, M., Philips, Z., Robinson, M., Ginnelly, L., Bakhai, A., Abrams, K., Cooper, N., Packham, C., Alfakih, K., Hall, A. and Gray, D. (2005) Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? International Journal of Cardiology, 100 (2). pp. 229-240. ISSN 0167-5273

Abstract

Metadata

Authors/Creators:
  • Palmer, S.
  • Sculpher, M.
  • Philips, Z.
  • Robinson, M.
  • Ginnelly, L.
  • Bakhai, A.
  • Abrams, K.
  • Cooper, N.
  • Packham, C.
  • Alfakih, K.
  • Hall, A.
  • Gray, D.
Institution: The University of York
Academic Units: The University of York > Centre for Health Economics (York)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds)
Depositing User: York RAE Import
Date Deposited: 15 May 2009 13:59
Last Modified: 18 Jun 2015 17:27
Published Version: http://dx.doi.org/10.1016/j.ijcard.2004.08.042
Status: Published
Publisher: Elsevier Science B.V.
Identification Number: 10.1016/j.ijcard.2004.08.042

Share / Export

Statistics